CARGO Therapeutics, Inc. (CRGX)
NASDAQ: CRGX · Real-Time Price · USD
4.230
+0.010 (0.24%)
At close: May 30, 2025, 4:00 PM
4.250
+0.020 (0.47%)
After-hours: May 30, 2025, 4:00 PM EDT
CARGO Therapeutics Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for CARGO Therapeutics stock ranges from a low of $3.00 to a high of $7.00. The average analyst price target of $4.67 forecasts a 10.40% increase in the stock price over the next year.
Price Target: $4.67 (+10.40%)
Analyst Consensus: Hold
* Price targets were last updated on Jan 30, 2025.
Analyst Ratings
The average analyst rating for CARGO Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 6 | 6 | 6 | 6 | 6 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $32 → $7 | Strong Buy → Hold | Downgrades | $32 → $7 | +65.48% | Jan 30, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $34 → $4 | Buy → Hold | Downgrades | $34 → $4 | -5.44% | Jan 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 30, 2025 |
| JP Morgan | JP Morgan | Buy → Sell Downgrades n/a | Buy → Sell | Downgrades | n/a | n/a | Jan 30, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 30, 2025 |
Financial Forecast
Revenue This Year
201.68M
from 127.50M
Increased by 58.18%
Revenue Next Year
n/a
from 201.68M
EPS This Year
-2.76
from -3.72
EPS Next Year
-2.88
from -2.76
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.56 | -1.85 | -2.12 | ||
| Avg | -2.76 | -2.88 | -2.56 | ||
| Low | -4.31 | -4.70 | -2.99 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.